Article Details
Retrieved on: 2018-04-23 07:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>BlackRock Inc</b>. lessened its stake in NovoCure (NASDAQ:NVCR) by 3.1% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,806,096 shares of the medical equipment provider's stock after selling 120,358 shares during the period.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here